Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
55 /100
HIGH RISK
Score updated Oct 27, 2026

SXTC — China SXT Pharmaceuticals, Inc. Dilution Risk Tracker

Track SXTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SXTC — Get alerts when the score changes →

As of October 27, 2026, China SXT Pharmaceuticals, Inc. (SXTC) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. China SXT Pharmaceuticals, Inc. has a market capitalization of $3.39M, 958.1K shares outstanding, 8 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $760.0K.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
57
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 42%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 48% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.80 approaching $1 threshold
💰 Capital Raise model 18%
• Active ATM program with $1M remaining capacity
🔔 Track SXTC — Get forecast alerts →

Market Data

Market Cap$3.39M
Shares Outstanding958.1K
Float740.8K
Cash$28.18M
Debt$648.9K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore55/100DilutionWatch score record
Shares Outstanding958.1KVerified float table or market cache
Public Float740.8KVerified float table or market cache
Market Cap$3.39MMarket data cache
Cash Runway96.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$760.0KSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 424B5 1, 6-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

SXTC SEC Filing Activity — Last 12 Months

Shares outstanding reported by SXTC on the cover page of its latest 10-K/10-Q: 958.1K as of March 31, 2026.

DilutionWatch recorded 4 registration or prospectus documents for SXTC (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)4Oct 09, 2026
EFFECTSEC declared a registration effective1Sep 17, 2026
SC 13Gpassive >5% holder filing1Oct 15, 2026
3initial insider ownership16Oct 21, 2026

Institutional Holdings

QoQ: ↑ 5.4% shares (2025Q4 vs prior)
8 institutional holders · 327.6K shares
#1 CITADEL ADVISORS LLC 150.6K shares
#2 Invesco Ltd. 85.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 53.7K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest721.0K
Days to Cover1.0
% of Float97.3%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-07-01
xbrl XBRL WARRANT 2024-04-05
424B5 ATM 2026-04-09
6-K 8K EVENT 2026-04-09
Full SEC filing analysis available with free account →

Recent News

Factual SXTC Dilution Snapshot

China SXT Pharmaceuticals, Inc. (SXTC) has a DilutionScore of 55/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SXTC's DilutionScore is currently 55/100 (High risk), with 5 score changes tracked over 89 days. The score improved from 43/100 (Medium risk).

Period Score Risk Level Duration
Oct 11 – Oct 27, 202655/100HIGH17 days
Oct 08 – Oct 10, 202643/100MEDIUM3 days
Sep 14 – Oct 07, 202638/100MEDIUM24 days
Aug 22 – Sep 13, 202640/100MEDIUM23 days
Aug 14 – Aug 21, 202634/100MEDIUM7 days
Jul 30 – Aug 13, 202638/100MEDIUM15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SXTC shares outstanding have increased 365.3% from 958.1K (Apr 2026) to 4.46M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 20264.46M740.8K▲ 5.52%
Apr 18, 2026958.1K702.0K▲ 28.33%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SXTC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SXTC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SXTC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SXTC
SXTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.